News

Filter

Emergent BioSolutions gets $1.25 billion BioThrax order for US government

04-10-2011

Emergent BioSolutions (NYSE: EBS) revealed yesterday that it has received an award to supply the US government…

BioThraxEmergent BioSolutionsFinancialMarkets & MarketingNorth AmericaPharmaceuticalVaccines

Back to top